These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 18510734)

  • 21. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
    Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathogenesis of neuromyelitis optica.
    Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
    Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
    Lana-Peixoto MA; Callegaro D
    Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4 by the Small Molecule Blocker Melanthioidine.
    Xu H; Gong Y; Jiao Y; Guo J; Zhao L; Yang J; Tong H; Sun M; Li M
    Curr Pharm Des; 2023; 29(10):793-802. PubMed ID: 36998134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
    Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
    J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tzartos JS; Stergiou C; Kilidireas K; Zisimopoulou P; Thomaidis T; Tzartos SJ
    PLoS One; 2013; 8(9):e74773. PubMed ID: 24086369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
    Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
    J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
    Crane JM; Lam C; Rossi A; Gupta T; Bennett JL; Verkman AS
    J Biol Chem; 2011 May; 286(18):16516-24. PubMed ID: 21454592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
    Mader S; Lutterotti A; Di Pauli F; Kuenz B; Schanda K; Aboul-Enein F; Khalil M; Storch MK; Jarius S; Kristoferitsch W; Berger T; Reindl M
    PLoS One; 2010 May; 5(5):e10455. PubMed ID: 20463974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.
    Ratelade J; Bennett JL; Verkman AS
    J Biol Chem; 2011 Dec; 286(52):45156-64. PubMed ID: 22069320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.
    Pisani F; Mastrototaro M; Rossi A; Nicchia GP; Tortorella C; Ruggieri M; Trojano M; Frigeri A; Svelto M
    J Biol Chem; 2011 Mar; 286(11):9216-24. PubMed ID: 21212277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.
    Ratelade J; Verkman AS
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1519-30. PubMed ID: 22713791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
    Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
    Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human NMO-IgG Induced Different Pathological and Immunological Changes in the CNS and Peripheral Tissues of Mice.
    Xiang W; Bai S; Wang K; Peng J; Wang Z; Han L; Xie C; Guan Y
    J Integr Neurosci; 2024 Jun; 23(6):119. PubMed ID: 38940087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.